tiprankstipranks
MustGrow Biologics (DE:0C0)
FRANKFURT:0C0
Germany Market
0C0
MustGrow Biologics
RESEARCH TOOLSreports

MustGrow Biologics (0C0) Ratios

0 Followers

MustGrow Biologics Ratios

DE:0C0's free cash flow for Q2 2026 was C$0.95. For the 2026 fiscal year, DE:0C0's free cash flow was decreased by C$ and operating cash flow was C$0.30. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 3.63 1.48 1.61 5.72 4.63
Quick Ratio
 3.34 0.51 1.12 5.72 4.63
Cash Ratio
 2.21 0.44 1.03 5.62 4.56
Solvency Ratio
 -2.62 -3.24 -1.51 -0.50 -2.94
Operating Cash Flow Ratio
 -1.44 -2.44 -1.24 -0.24 -2.11
Short-Term Operating Cash Flow Coverage
 -7.55 -11.69 -9.09 -0.48 -8.06
Net Current Asset Value
C$ 5.05MC$ 834.49KC$ 1.41MC$ 5.58MC$ 5.24M
Leverage Ratios
Debt-to-Assets Ratio
 0.07 0.19 0.10 0.11 0.11
Debt-to-Equity Ratio
 0.10 0.67 0.24 0.14 0.14
Debt-to-Capital Ratio
 0.09 0.40 0.19 0.12 0.13
Long-Term Debt-to-Capital Ratio
 0.03 0.13 0.05 0.02 0.06
Financial Leverage Ratio
 1.42 3.57 2.50 1.24 1.36
Debt Service Coverage Ratio
 -9.78 -8.31 -12.42 -1.09 -13.41
Interest Coverage Ratio
 -80.39 -19.97 0.00 0.00 -551.93
Debt to Market Cap
 0.02 0.02 <0.01 0.01 <0.01
Interest Debt Per Share
 <0.01 0.02 0.01 0.02 0.02
Net Debt to EBITDA
 0.92 0.05 0.51 8.95 1.13
Profitability Margins
Gross Profit Margin
52.78%17.03%75.56%91.84%100.00%
EBIT Margin
-132.52%-75.45%-1228.27%-14.37%-85750.50%
EBITDA Margin
-131.69%-74.84%-1228.27%-14.37%-85750.50%
Operating Profit Margin
-132.57%-75.45%-1284.91%-17.08%-85750.50%
Pretax Profit Margin
-156.24%-87.58%-1228.27%-14.37%-85905.87%
Net Profit Margin
-174.40%-87.58%-1228.27%-14.37%-85905.87%
Continuous Operations Profit Margin
-156.24%-87.58%-1228.27%-14.37%-85905.87%
Net Income Per EBT
111.62%100.00%100.00%100.00%100.00%
EBT Per EBIT
117.86%116.07%95.59%84.09%100.18%
Return on Assets (ROA)
-77.72%-234.64%-90.26%-9.76%-78.01%
Return on Equity (ROE)
-218.75%-837.00%-225.33%-12.12%-106.24%
Return on Capital Employed (ROCE)
-81.56%-613.93%-202.97%-14.06%-99.31%
Return on Invested Capital (ROIC)
-76.03%-430.85%-175.56%-12.69%-92.62%
Return on Tangible Assets
-77.72%-234.64%-100.99%-9.76%-78.01%
Earnings Yield
-20.04%-21.19%-8.24%-1.05%-3.21%
Efficiency Ratios
Receivables Turnover
 2.22 119.61 3.87 49.70 0.07
Payables Turnover
 1.05 4.19 0.04 1.20 0.00
Inventory Turnover
 2.66 3.44 0.07 0.00 0.00
Fixed Asset Turnover
 0.00 254.09 2.21 0.00 0.00
Asset Turnover
 0.45 2.68 0.07 0.68 <0.01
Working Capital Turnover Ratio
 0.96 6.03 0.11 0.83 <0.01
Cash Conversion Cycle
 -45.88 22.01 -3.93K -297.94 4.95K
Days of Sales Outstanding
 164.37 3.05 94.25 7.34 4.95K
Days of Inventory Outstanding
 137.27 106.13 5.37K 0.00 0.00
Days of Payables Outstanding
 347.52 87.17 9.39K 305.29 0.00
Operating Cycle
 301.64 109.18 5.46K 7.34 4.95K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.04 -0.09 -0.07 >-0.01 -0.07
Free Cash Flow Per Share
 -0.07 -0.12 -0.07 >-0.01 -0.07
CapEx Per Share
 0.02 0.03 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.52 1.30 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -1.91 -3.37 -894.57K -73.69K 0.00
Capital Expenditure Coverage Ratio
 -1.91 -3.37 -894.57K -73.69K 0.00
Operating Cash Flow Coverage Ratio
 -5.52 -8.66 -6.91 -0.39 -4.29
Operating Cash Flow to Sales Ratio
 -0.89 -0.61 -8.99 -0.06 -502.78
Free Cash Flow Yield
-17.48%-19.15%-6.03%-0.46%-1.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.48 -4.85 -12.14 -95.08 -31.17
Price-to-Sales (P/S) Ratio
 7.77 4.13 149.08 13.66 26.78K
Price-to-Book (P/B) Ratio
 5.50 39.49 27.35 11.53 33.12
Price-to-Free Cash Flow (P/FCF) Ratio
 -5.72 -5.22 -16.58 -218.36 -53.26
Price-to-Operating Cash Flow Ratio
 -9.76 -6.77 -16.58 -218.36 -53.26
Price-to-Earnings Growth (PEG) Ratio
 -0.65 -0.13 -0.02 1.08 -0.55
Price-to-Fair Value
 5.50 39.49 27.35 11.53 33.12
Enterprise Value Multiple
 -4.99 -5.47 -11.63 -86.13 -30.10
Enterprise Value
 20.95M 33.91M 56.86M 58.31M 167.24M
EV to EBITDA
 -4.99 -5.47 -11.63 -86.13 -30.10
EV to Sales
 6.56 4.09 142.85 12.37 25.81K
EV to Free Cash Flow
 -4.83 -5.17 -15.89 -197.81 -51.34
EV to Operating Cash Flow
 -7.36 -6.70 -15.89 -197.81 -51.34
Tangible Book Value Per Share
 0.08 0.02 0.03 0.11 0.11
Shareholders’ Equity Per Share
 0.08 0.02 0.04 0.11 0.11
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.05 0.15 <0.01 0.09 <0.01
Net Income Per Share
 -0.09 -0.13 -0.09 -0.01 -0.11
Tax Burden
 1.12 1.00 1.00 1.00 1.00
Interest Burden
 1.18 1.16 1.00 1.00 1.00
Research & Development to Revenue
 0.15 0.06 1.94 0.18 73.45
SG&A to Revenue
 1.49 0.74 9.60 0.66 697.47
Stock-Based Compensation to Revenue
 0.40 0.17 3.70 0.29 261.54
Income Quality
 0.57 0.70 0.73 0.44 0.59
Currency in CAD